Real-time enrollment status for this interstitial lung diseases clinical trial
Current Status
Recruiting
Checked: November 9, 2026 at 8:53 PM UTC
| NCT Number | NCT07540988 |
| Recruiting Status | Recruiting |
| Condition | Interstitial Lung Diseases |
| Phase | PHASE3 |
| Target Enrollment | 466 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | October 28, 2026 (1 week ago) |
As of November 9, 2026: Clinical trial NCT07540988 is currently recruiting participants. This phase3 study for interstitial lung diseases is actively seeking new participants at 30 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07540988 is actively recruiting participants as of November 9, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07540988 was last updated 1 week ago (October 28, 2026). HelloStudys verifies this status automatically.